Anebulo Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-022350
- Form type
- 10-Q
- CIK
- 0001815974
- Primary document
- https://www.sec.gov/Archives/edgar/data/1815974/000149315225022350/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Anebulo Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.3M | - | - |
| Net Income | $-2.2M | - | - |
| Eps Basic | -0.05 | - | - |
| Eps Diluted | -0.05 | - | - |
| Cash And Equivalents | $10.4M | - | - |
| Total Assets | $10.7M | - | - |
| Total Liabilities | $963,821 | - | - |
| Shareholders Equity | $9.7M | - | - |
| Operating Cash Flow | $-1.3M | - | - |